Literature DB >> 26893066

Optimizing mouse models for precision cancer prevention.

Clémentine Le Magnen1, Aditya Dutta1, Cory Abate-Shen2.   

Abstract

As cancer has become increasingly prevalent, cancer prevention research has evolved towards placing a greater emphasis on reducing cancer deaths and minimizing the adverse consequences of having cancer. 'Precision cancer prevention' takes into account the collaboration of intrinsic and extrinsic factors in influencing cancer incidence and aggressiveness in the context of the individual, as well as recognizing that such knowledge can improve early detection and enable more accurate discrimination of cancerous lesions. However, mouse models, and particularly genetically engineered mouse (GEM) models, have yet to be fully integrated into prevention research. In this Opinion article, we discuss opportunities and challenges for precision mouse modelling, including the essential criteria of mouse models for prevention research, representative success stories and opportunities for more refined analyses in future studies.

Entities:  

Mesh:

Year:  2016        PMID: 26893066      PMCID: PMC5517771          DOI: 10.1038/nrc.2016.1

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  128 in total

1.  A molecular signature predictive of indolent prostate cancer.

Authors:  Shazia Irshad; Mukesh Bansal; Mireia Castillo-Martin; Tian Zheng; Alvaro Aytes; Sven Wenske; Clémentine Le Magnen; Paolo Guarnieri; Pavel Sumazin; Mitchell C Benson; Michael M Shen; Andrea Califano; Cory Abate-Shen
Journal:  Sci Transl Med       Date:  2013-09-11       Impact factor: 17.956

Review 2.  Humanized mice for immune system investigation: progress, promise and challenges.

Authors:  Leonard D Shultz; Michael A Brehm; J Victor Garcia-Martinez; Dale L Greiner
Journal:  Nat Rev Immunol       Date:  2012-10-12       Impact factor: 53.106

3.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.

Authors:  L A Donehower; M Harvey; B L Slagle; M J McArthur; C A Montgomery; J S Butel; A Bradley
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

4.  Lung cancer signatures in plasma based on proteome profiling of mouse tumor models.

Authors:  Ayumu Taguchi; Katerina Politi; Sharon J Pitteri; William W Lockwood; Vitor M Faça; Karen Kelly-Spratt; Chee-Hong Wong; Qing Zhang; Alice Chin; Kwon-Sik Park; Gary Goodman; Adi F Gazdar; Julien Sage; Daniela M Dinulescu; Raju Kucherlapati; Ronald A Depinho; Christopher J Kemp; Harold E Varmus; Samir M Hanash
Journal:  Cancer Cell       Date:  2011-09-13       Impact factor: 31.743

Review 5.  Mouse models of cancer: does the strain matter?

Authors:  Kent W Hunter
Journal:  Nat Rev Cancer       Date:  2012-01-19       Impact factor: 60.716

Review 6.  Tamoxifen: a most unlikely pioneering medicine.

Authors:  V Craig Jordan
Journal:  Nat Rev Drug Discov       Date:  2003-03       Impact factor: 84.694

7.  Overtreatment of men with low-risk prostate cancer and significant comorbidity.

Authors:  Timothy J Daskivich; Karim Chamie; Lorna Kwan; Jessica Labo; Roland Palvolgyi; Atreya Dash; Sheldon Greenfield; Mark S Litwin
Journal:  Cancer       Date:  2010-11-29       Impact factor: 6.860

Review 8.  The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates.

Authors:  Katherine E Poruk; D Z Gay; K Brown; J D Mulvihill; K M Boucher; C L Scaife; M A Firpo; S J Mulvihill
Journal:  Curr Mol Med       Date:  2013-03       Impact factor: 2.222

Review 9.  Precision medicine for cancer with next-generation functional diagnostics.

Authors:  Adam A Friedman; Anthony Letai; David E Fisher; Keith T Flaherty
Journal:  Nat Rev Cancer       Date:  2015-11-05       Impact factor: 60.716

Review 10.  Precision cancer mouse models through genome editing with CRISPR-Cas9.

Authors:  Haiwei Mou; Zachary Kennedy; Daniel G Anderson; Hao Yin; Wen Xue
Journal:  Genome Med       Date:  2015-06-09       Impact factor: 11.117

View more
  30 in total

Review 1.  Cancer Prevention: Lessons Learned and Future Directions.

Authors:  Barbara K Dunn; Barnett S Kramer
Journal:  Trends Cancer       Date:  2016-12

Review 2.  Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care.

Authors:  Christopher M Hartshorn; Michelle S Bradbury; Gregory M Lanza; Andre E Nel; Jianghong Rao; Andrew Z Wang; Ulrich B Wiesner; Lily Yang; Piotr Grodzinski
Journal:  ACS Nano       Date:  2017-12-22       Impact factor: 15.881

3.  Trefoil factor 1 inhibits epithelial-mesenchymal transition of pancreatic intraepithelial neoplasm.

Authors:  Junpei Yamaguchi; Yukihiro Yokoyama; Toshio Kokuryo; Tomoki Ebata; Atsushi Enomoto; Masato Nagino
Journal:  J Clin Invest       Date:  2018-07-23       Impact factor: 14.808

4.  Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition.

Authors:  Aditya Dutta; Sukanya Panja; Renu K Virk; Jaime Yeji Kim; Roseann Zott; Serge Cremers; David M Golombos; Deli Liu; Juan Miguel Mosquera; Elahe A Mostaghel; Christopher E Barbieri; Antonina Mitrofanova; Cory Abate-Shen
Journal:  Eur Urol       Date:  2017-04-04       Impact factor: 20.096

Review 5.  Preclinical mouse solid tumour models: status quo, challenges and perspectives.

Authors:  Nicolas Gengenbacher; Mahak Singhal; Hellmut G Augustin
Journal:  Nat Rev Cancer       Date:  2017-10-27       Impact factor: 60.716

Review 6.  Lifestyle and Environmental Approaches for the Primary Prevention of Hepatocellular Carcinoma.

Authors:  Tracey G Simon; Andrew T Chan
Journal:  Clin Liver Dis       Date:  2020-08-25       Impact factor: 6.126

7.  NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer Initiation.

Authors:  Alexandros Papachristodoulou; Aditya Dutta; Antonio Rodriguez-Calero; Sukanya Panja; Elizabeth Margolskee; Renu K Virk; Teresa A Milner; Luis Pina Martina; Jaime Y Kim; Matteo Di Bernardo; Alanna B Williams; Elvis A Maliza; Joseph M Caputo; Christopher Haas; Vinson Wang; Guarionex Joel De Castro; Sven Wenske; Hanina Hibshoosh; James M McKiernan; Michael M Shen; Mark A Rubin; Antonina Mitrofanova; Cory Abate-Shen
Journal:  Cancer Discov       Date:  2021-04-23       Impact factor: 39.397

Review 8.  Precision and Immunoprevention Strategies for Tobacco-Related Head and Neck Cancer Chemoprevention.

Authors:  Sara M Centuori; Carlos Caulin; Julie E Bauman
Journal:  Curr Treat Options Oncol       Date:  2021-05-15

Review 9.  Controversies around epithelial-mesenchymal plasticity in cancer metastasis.

Authors:  Elizabeth D Williams; Dingcheng Gao; Andrew Redfern; Erik W Thompson
Journal:  Nat Rev Cancer       Date:  2019-10-30       Impact factor: 60.716

Review 10.  Systems genetics analysis of oral squamous cell carcinoma susceptibility using the mouse model: current position and new perspective.

Authors:  Aysar Nashef; Nayrouz Qahaz; Imad Abu El-Naaj; Fuad A Iraqi
Journal:  Mamm Genome       Date:  2021-06-21       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.